Data / Form D filings / Radionetics Oncology, Inc.
Radionetics Oncology, Inc.: Form D filing
Radionetics Oncology, Inc., a pharmaceuticals company in Menlo Park, CA, filed a Form D with the SEC in 2023. The latest, on August 15, 2023, reports $54.2 million sold of a $68.7 million offering to 6 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 70 WILLOW STREET, SUITE 200, Menlo Park, CA, 94025
- Phone
- (858) 218-6617
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1989304
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 15, 2023 | New notice | $68,711,758 | $54,211,759 | $14,499,999 | 6 | Aug 1, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Brett Ewald | Executive Officer | |
| Andrew Schwab | Director | |
| Umesh Gangadharmath | Executive Officer | |
| Dan Estes | Executive Officer, Director | |
| Istvan Molnar | Executive Officer | |
| Yunfei Zhu | Executive Officer | |
| Ana Kusnetzow | Executive Officer | |
| Scott Struthers | Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Aug 14, 2023 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Radionetics Oncology, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.